Clinical trials
Recruiting Carcinoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 1 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Emory University | 1 |
| Imperial College London | 1 |
| Peking University People's Hospital | 1 |
| Stanford University | 1 |
| Yonsei University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 8 |
| Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
| Neoplasms, Glandular and Epithelial | 2 |
| Ovarian Neoplasms | 2 |
| Skin Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Basal Cell Carcinoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.